VintaBio

VintaBio is a contract development and manufacturing organization (CDMO) specializing in the production of viral vectors, which are engineered viruses used as delivery vehicles for cell and gene therapies. With over a century of combined experience in the cell and gene therapy field, the company’s development and manufacturing teams have played key roles in the creation of some of the most advanced therapies on the market today. Headquartered in Philadelphia, a hub for cell and gene therapy innovation, VintaBio focuses on the development and production of consistently high-quality viral vectors — a critical and currently underserved area in CGT development.